Scinovex
article Open AccessTop 1% cited

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

American Journal of Transplantation · 2017 · Vol. 18(2) · pp. 293–307
Mark HaasAlexandre LoupyCarmen LefaucheurCandice RoufosseDenis GlotzDaniel SerónBrian J. NankivellPhilip F. HalloranRobert B. ColvinEnver AkalinNada AlachkarSerena M. BagnascoYassine BouatouJan U. BeckerLynn D. CornellJ.P. Duong Van HuyenIan W. GibsonEdward S. KrausRoslyn B. MannonMaarten NaesensVolker NickeleitPeter NickersonDorry L. SegevHarsharan K. SinghMark D. StegallParmjeet RandhawaLorraine C. RacusenKim SolezMichael Mengel
Renal Transplantation Outcomes and TreatmentsRenal Diseases and GlomerulopathiesCytomegalovirus and herpesvirus researchMedicineClinical trialSequelaSurrogate endpointKidney transplantationInternal medicinePathologyKidneyImmunologyOncology

MeSH terms

Graft RejectionHumansInflammationIsoantibodiesPostoperative ComplicationsPrognosisT-LymphocytesKidney TransplantationResearch ReportHigh-Throughput Nucleotide Sequencing
Citations
1,013
FWCI
79.81
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials · Scinovex